» Articles » PMID: 36494325

Is Whole-body Magnetic Resonance Imaging a Source of Anxiety in Oncological Patients?

Overview
Specialty Oncology
Date 2022 Dec 9
PMID 36494325
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Magnetic resonance often produces feelings of anxiety before, or during, the examination. The aim of this study was to assess anxiety and potential causes of anxiety in cancer patients undergoing whole-body magnetic resonance imaging (WB-MRI).

Methods: This monocentric study recruited 70 cancer patients who were scheduled to undergo WB-MRI for detection, staging or therapy monitoring. At baseline (prior to the WB-MRI), assessments were performed using the State-Trait Anxiety Inventory (STAI-Y 1), Illness Perception Questionnaire (IPQ-R), Big Five Inventory (BIF-10) and Revised Life Orientation Test (LOT-R), while at the end of the WB-MRI examination the patients repeated the STAI-Y 1 questionnaire and were asked to indicate their preference between WB-MRI and computed tomography.

Results: We found a positive correlation between pre- and post-examination STAI-Y 1 scores (r = 0.536, p < .0001), with no significant difference between them. Pre-examination STAI-Y 1 scores had a negative correlation with the emotional stability in the BIF-10 questionnaire (r = -0.47, p = .001) and a positive correlation with emotional representation (r = 0.57, p = .001) in IPQ-R. The post-examination STAI-Y 1 had a negative correlation with optimistic orientation (r = -0.59, p = .001).

Conclusions: The anxiety associated with a WB-MRI examination was only in small part associated with the examination itself, and in fact, most patients preferred WB-MRI to computed tomography. Concern with the outcome of the examination was likely a greater source of anxiety.

Citing Articles

Predictors of anxiety in patients undergoing magnetic resonance imaging scans: a multicenter cross-sectional study.

Masalma R, Zidan T, Amasheh S, Maree M, Alhanbali M, Shawahna R BMC Psychiatry. 2024; 24(1):633.

PMID: 39333965 PMC: 11437789. DOI: 10.1186/s12888-024-06091-6.


Whole-body MRI in oncology: acquisition protocols, current guidelines, and beyond.

Zugni F, Mariani L, Lambregts D, Maggioni R, Summers P, Granata V Radiol Med. 2024; 129(9):1352-1368.

PMID: 38990426 DOI: 10.1007/s11547-024-01851-6.


Is whole-body magnetic resonance imaging a source of anxiety in oncological patients?.

Mazzocco K, Busacchio D, Summers P, Marzorati C, Pricolo P, Petralia G Cancer Rep (Hoboken). 2022; 6(3):e1737.

PMID: 36494325 PMC: 10026313. DOI: 10.1002/cnr2.1737.

References
1.
Thorpe S, Salkovskis P, Dittner A . Claustrophobia in MRI: the role of cognitions. Magn Reson Imaging. 2008; 26(8):1081-8. DOI: 10.1016/j.mri.2008.01.022. View

2.
Keeling M, Bambrough J, Simpson J . Depression, anxiety and positive affect in people diagnosed with low-grade tumours: the role of illness perceptions. Psychooncology. 2012; 22(6):1421-7. DOI: 10.1002/pon.3158. View

3.
Zenger M, Glaesmer H, Hockel M, Hinz A . Pessimism predicts anxiety, depression and quality of life in female cancer patients. Jpn J Clin Oncol. 2010; 41(1):87-94. DOI: 10.1093/jjco/hyq168. View

4.
Nozzolillo R, Ercolani P, Giovagnoni A, De Nigris E, Barbini N, Mariani L . [Psychologic reactions of patients undergoing magnetic resonance imaging. Preliminary study]. Radiol Med. 1991; 81(5):601-4. View

5.
Gillessen S, Attard G, Beer T, Beltran H, Bossi A, Bristow R . Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol. 2017; 73(2):178-211. DOI: 10.1016/j.eururo.2017.06.002. View